Free Newsletter
Shift in enforcement halves FDA warnings
Think the FDA has been falling all over itself to issue warning letters lately? Think again. A look at agency statistics showed that the number of warning letters actually dropped by half--yes, half--in the last 10 years. Apparently, when FDA changed its rules in 2002, requiring all warning letters to go through its chief counsel's office, the number of missives immediately dropped. In fiscal 2001, the agency sent 1,032; in 2002, it dispatched 538, and and in 2003, 471.
Agency chief Andrew von Eschenbach says that the difference lies only in the seriousness of the letters sent. In the past warning letters were sent out for minor as well as major problems; now they're reserved for serious concerns, he said. And David Elder, enforcement guru at the agency, said counting letters is at best a simplistic measure of its performance. But ex-FDA head David Kessler told the Wall Street Journal that the number of warning letters has "always been one of the surrogate measures of FDA's enforcement performance...[A]ny significant drop raises significant questions."
- see the NYT piece
Related Articles:
Top 10 Drug Warnings and Recalls of 2007
FDA: Expect more early warnings
1300 new hires planned for FDA expansion
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: